An analysis of 96,000 cases of COVID-19, published today in The Lancet, shows that patients who were treated with the antimalarial drugs chloroquine or hydroxychloroquine had a death rate that was roughly twice as high as for patients who weren’t.
An analysis of 96,000 cases of COVID-19, published today in The Lancet, shows that patients who were treated with the antimalarial drugs chloroquine or hydroxychloroquine had a death rate that was roughly twice as high as for patients who weren’t.